Smart IP Strategy for Life Sciences Startups
Are you and your startup active in the life science sector? In no other field is a deliberate IP strategy more crucial for commercial success than in the life science industry.
Collaborations with large corporations, other startups and research providers require sharing your ideas and results with others as wells as receiving confidential information which may impact your own activities. Thorough agreements are therefore vital to ensure optimal outcome of such endeavors for your company.
Moreover, the requirements for protecting chemical, pharmaceutical and biotechnological inventions are far more demanding than for other technologies. Come and join us and get a deeper understanding of how to protect your knowhow and learn about common pitfalls and how to avoid mistakes along your journey.
Selected companies will be invited to join a workshop where experts will discuss the following topics:
- Specific patent requirements and obstacles in the field of life science
- Research and collaboration contracts and exchange of information
- Presentation of a case study of a successful startup to illustrate how the IP portfolio was built up in a targeted manner
Experts
Demian Stauber is a partner at Rentsch Partner AG being active as an attorney at law in the fields of intellectual property, information technology and contract law. He counsels innovative small and medium-sized companies in drafting and negotiating of contracts.
Christian Ebner is European Patent Attorney at Rentsch Partner AG. He studied chemistry with emphasis organic chemistry at ETH Zurich and the Scripps Research Institute in La Jolla USA.
